Poulton Jeffrey V.

EDGAR CIK 0001782962

Alnylam Pharmaceuticals, Inc. - ALNY

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CFO
EVP, Chief Financial Officer
Direct Buys
0
$0
0 Shares
Direct Sells
4
($3.22) M
-9,696 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/04/2026
03/06/2026
Sell
-2,468 @ $323.08
 ($797,351) 61,805 (-3.84%) Direct
03/02/2026
03/04/2026
Sell
-2,206 @ $327.65
 ($722,801) 64,273 (-3.32%) Direct
02/13/2026
02/17/2026
Sell
-2,242 @ $310.08
 ($695,201) 59,802 (-3.61%) Direct
01/12/2026
01/14/2026
Sell
-2,780 @ $362.87
 ($1,008,766) 57,465 (-4.61%) Direct